Advertisement
Here are the top health stories for the day:
Three private hospitals in Telangana served notices sue to high c-section rates
The Health Department officials in Telangana have taken decisive action by seizing the labor rooms of three private hospitals. Two of these hospitals are situated in the temple town of Vemulwada, while the third is located in the district headquarters town of Sircilla. This action comes in response to alarming reports indicating an exceptionally high rate of cesarean (C-section) deliveries, reaching 100% during the 2023-24 period.
Under the directive of Collector Anuraag Jayanti, the Health Department is intensifying efforts to curb unwarranted C-section deliveries. Notices have been promptly issued to the management of the three implicated hospitals – Amrutha Nursing Home and Vasudeva Hospital in Vemulawada, and Sarayu Hospital in Sircilla. They have been instructed to refrain from conducting any deliveries until further directives are received from the government. Dr. Suman Mohan Rao, the District Medical and Health Officer, affirmed this course of action in an official statement.
Use of fairness cream driving surge in kidney problems in India: Study
A recent study published in Kidney International highlights the concerning correlation between the widespread use of skin fairness creams and an increase in kidney problems in India. The obsession with fair skin in society has fueled a lucrative market for these creams, but their high mercury content poses serious health risks, particularly to the kidneys.
The study, conducted by researchers including Dr. Sajeesh Sivadas from the Department of Nephrology at Aster MIMS Hospital in Kottakkal, Kerala, found a direct link between the use of fairness creams and Membranous Nephropathy (MN), a condition that damages kidney filters and leads to protein leakage.
Reference: NELL-1 associated membranous nephropathy linked to skin fairness cream use- insights from an Indian case series, Ranjit Narayanan, Sajeesh Sivadas, Anila Abraham Kurien, DOI:https://doi.org/10.1016/j.kint.2024.03.025
Drug safety alert: IPC flags ADR linked to Cefuroxime, Nimesulide, Dutasteride plus Tamsulosin and some beta-blockers
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert, has revealed adverse drug reactions linked with the popular antibiotic Cefuroxime, fixed-dose combination drug Dutasteride plus Tamsulosin, non-steroidal anti-inflammatory drug Nimesulide, and beta blockers such as Metoprolol, Propranolol, Atenolol.
In accordance with the drug safety alert, Cefuroxime which is an antibiotic, indicated for lower and upper respiratory tract infections, urinary tract infections (UTI), gynecological infections, and skin or soft tissue infections, etc can cause Acute Generalized Exanthematous Pustulosis (AGEP).
For more information, click on the link below:
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.